Inhibition of CaMKII can, therefore, protect against diastolic Ca2+ release and prevent arrhythmias, as illustrated in murine models of CPVT (Bezzerides et al., 2019; Liu et al., 2011). Here, CAMK2G is linked to catecholaminergic polymorphic ventricular tachycardia.